Board hikes authorised capital, approves share swap to acquire Archit Life Science
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.2 pts less than Nifty Microcap 250 and 1.6 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Board raised authorised share capital from Rs 25 Cr to Rs 60 Cr and approved issuing up to 3.72 Cr equity shares at Rs 65 each (Rs 55 premium on Rs 10 face value) through a preferential share swap. The shares will be exchanged to acquire 1.86 Cr shares (92.20%) of Archit Life Science Limited, valued at Rs 130 per share. Allottees include promoter family members and non-promoter investors. Needs shareholder and regulatory approval.
Share swap will dilute existing shareholders but adds Archit Life Science as a subsidiary. Pending shareholder and other approvals.